Regulatory News: ABIONYX Pharma, (FR0012616852 – ABNX – eligible for the PEA PME), a next-generation biopharmaceutical company developing innovative treatments for sepsis and intensive care based on a ...

November 02, 2026 - PRESSADVANTAGE - Simple Dental, a general and emergency dental practice in South Gate, California, ...

I congratulate Emma Malchau Carlsen and colleagues on the DURATION trial,1 an important pragmatic randomised study showing that among late-preterm and term neonates selected for continued treatment of ...

Early-onset neonatal sepsis (EONS) remains a challenging diagnosis in clinical practice, with limited available paraclinical data. This study aims to analyze the utility of two cytokines determined ...

A simple daily blood test could help critically ill sepsis patients come off antibiotics sooner, potentially reducing drug ...

Dietary fiber and microbial metabolites influence intestinal barrier function and immune responses, with animal studies ...

Add Yahoo as a preferred source to see more of our stories on Google. Sepsis is a life-threatening condition in which the body overreacts to an infection and starts attacking its own tissues and ...

Founder Patrick Soon-Shiong renewed his “NantX coming soon” teaser after the Binance theft, spotlighting his separate financial-services venture.

A new editorial in Anesthesiology and Perioperative Science maps how machine-learning risk models, immunometabolic targets ...

Testing newborns for sepsis will be faster and more accurate under a world-first blood test being developed in WA that could save the lives of thousands of babies every year.

Federal regulations will soon count secondary infection readmissions the same as other disorders, meaning hospitals must ...

Sepsis is a potentially fatal condition in which the body has a systemic inflammatory response to an infection. The history of sepsis stretches back to ancient Greece, but it is still a serious ...